These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 23278778

  • 1. Multidrug-resistant tuberculosis in an HIV-infected girl.
    Shah I, Mohanty S.
    Natl Med J India; 2012; 25(4):210-1. PubMed ID: 23278778
    [Abstract] [Full Text] [Related]

  • 2. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS.
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIV.
    Zuur MA, Akkerman OW, Touw DJ, van der Werf TS, Cobelens F, Burger DM, Grobusch MP, Alffenaar JW.
    Eur Respir J; 2016 Sep; 48(3):932-4. PubMed ID: 27288037
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.
    Walls G, Bulifon S, Breysse S, Daneth T, Bonnet M, Hurtado N, Molfino L.
    Glob Health Action; 2015 Sep; 8():25964. PubMed ID: 25623609
    [Abstract] [Full Text] [Related]

  • 9. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
    Lienhardt C, Davies G.
    Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Adverse drug reactions in multidrug-resistant tuberculosis].
    Palmero D, Cruz V, Museli T, Pavlovsky H, Fernández J, Waisman J.
    Medicina (B Aires); 2010 May; 70(5):427-33. PubMed ID: 20920959
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM, Shah NS, Mlisana K, Moodley P, Allana S, Campbell A, Johnson BA, Master I, Mthiyane T, Lachman S, Larkan LM, Ning Y, Malik A, Smith JP, Gandhi NR.
    Clin Infect Dis; 2018 Apr 03; 66(8):1246-1253. PubMed ID: 29293906
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings.
    Wilson JW, Nilsen DM, Marks SM.
    Ann Am Thorac Soc; 2020 Jan 03; 17(1):16-23. PubMed ID: 31365831
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan 13; 106(1):1-6. PubMed ID: 8750533
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.